Last Updated Sep 11, 2009 4:05 PM EDT
Conversely, the study will be greeted with joy by the lawyers suing Bayer, who believe that Yaz causes a greater-then-usual number of blood clots compared to older pills because of its new progesterone ingredient.
Yaz uses drospirenone as its progesterone ingredient. The study said there was a 6.3-fold increase in VT risk for drospirenone. The safest progesterone was levonorgestrel, the study said, which is found in Teva's Seasonique (that's the one that gives you only four periods a year).
The Dutch authors of the survey concluded:
With such a large number of women using oral contraceptives, even the smallest increase of side effects will affect many. Knowledge of these risks and efforts to reduce them are of crucial importance. Our results clearly show that the safest option with regard to the risk of venous thrombosis is an oral contraceptive containing levonorgestrel combined with a low dose of oestrogen.
- Previous items on Bayer and contraception:
- Suits Claim Bayer's Yaz Caused 50 Deaths; Novel Theory of Blood Clot Causation
- What Bayer's Qlaira Application May Reveal About Yaz Clot Risks
- Yaz Is Bayer's Top Seller Despite Blood Clot Suits, Ad Woes
- Bayer Sued Over Yaz Death, Blood Clots
- Bayer Hires The Hills' Lo Bosworth to Tout Birth Control Pill Yaz
- Why the Bayer-Yaz Settlement Will Not Change Drug Advertising Forever
- Bayer's Advertising for Contraceptive Yaz Was "Misleading"
- J&J Settles Fatal Patch Cases, So Why Is This Thing Still on the Market?